Effect and safety of cytokine-induced killer (CIK) cell immunotherapy in patients with breast cancer: A meta-analysis

BACKGROUND: Breast cancer (BC) is considered a systemic disease with a primarily locoregional component. The accumulation of basic researches and clinical studies related to cytokine-induced killer (CIK) cells has confirmed their safety and feasibility in treating BC. By searching the PubMed, Embase...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jianxin, Hu, Junfeng, Liu, Xiandong, Hu, Chao, Li, Ming, Han, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5750
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662403/
https://www.ncbi.nlm.nih.gov/pubmed/29049237
http://dx.doi.org/10.1097/MD.0000000000008310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662403/
https://www.ncbi.nlm.nih.gov/pubmed/29049237
http://dx.doi.org/10.1097/MD.0000000000008310

Ejemplares similares